Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
in the sixth column, expiration of approval, of row 316, Cycloxydim, the date is replaced by ‘31 May 2023’;
in the sixth column, expiration of approval, of row 317, 6-Benzyladenine, the date is replaced by ‘31 May 2024’;
in the sixth column, expiration of approval, of row 322, Hymexazol, the date is replaced by ‘31 May 2023’;
in the sixth column, expiration of approval, of row 323, Dodine, the date is replaced by ‘31 May 2024’;
in the sixth column, expiration of approval, of row 326, Indolylbutyric acid, the date is replaced by ‘31 May 2023’;
in the sixth column, expiration of approval, of row 328, Tau-fluvalinate, the date is replaced by ‘31 May 2024’;
in the sixth column, expiration of approval, of row 329, Clethodim, the date is replaced by ‘31 May 2023’;
in the sixth column, expiration of approval, of row 330, Bupirimate, the date is replaced by ‘31 May 2024’;
in the sixth column, expiration of approval, of row 333, 1-decanol, the date is replaced by ‘31 May 2024’;
in the sixth column, expiration of approval, of row 334, Isoxaben, the date is replaced by ‘31 May 2024’;
in the sixth column, expiration of approval, of row 335, Fluometuron, the date is replaced by ‘31 May 2024’;
in the sixth column, expiration of approval, of row 337, Carboxin, the date is replaced by ‘31 May 2023’;
in the sixth column, expiration of approval, of row 339, Dazomet, the date is replaced by ‘31 May 2023’;
in the sixth column, expiration of approval, of row 340, Metaldehyde, the date is replaced by ‘31 May 2023’;
in the sixth column, expiration of approval, of row 341, Sintofen, the date is replaced by ‘31 May 2024’;
in the sixth column, expiration of approval, of row 342, Fenazaquin, the date is replaced by ‘31 May 2023’;
in the sixth column, expiration of approval, of row 343, Azadirachtin, the date is replaced by ‘31 May 2024’;
in the sixth column, expiration of approval, of row 344, Diclofop, the date is replaced by ‘31 May 2023’;
in the sixth column, expiration of approval, of row 345, Lime sulphur, the date is replaced by ‘31 May 2024’;
in the sixth column, expiration of approval, of row 346, Aluminium sulfate, the date is replaced by ‘31 May 2024’;
in the sixth column, expiration of approval, of row 348, Paclobutrazol, the date is replaced by ‘31 May 2023’;
in the sixth column, expiration of approval, of row 349, Pencycuron, the date is replaced by ‘31 May 2024’;
in the sixth column, expiration of approval, of row 350, Tebufenozide, the date is replaced by ‘31 May 2024’;
in the sixth column, expiration of approval, of row 351, Dithianon, the date is replaced by ‘31 May 2024’;
in the sixth column, expiration of approval, of row 352, Hexythiazox, the date is replaced by ‘31 May 2024’;
in the sixth column, expiration of approval, of row 353, Flutriafol, the date is replaced by ‘31 May 2024’.